Healthcare Services Group reports Q3 results amid challenges
Healthcare Services Group Inc. shares Q3 results, highlighting challenges in the nursing and personal care facilities sector.
Marti Technologies Wins Key Legal Battle Over Ride-Sharing
Marti Technologies, Inc. secures a significant legal victory as the Istanbul Regional Court dismisses claims against its ride-sharing platform, bolstering its market position.
GSK Reports Positive Phase I Data for Ovarian Cancer Drug
GSK plc presents encouraging results for Mo-Rez, a new treatment for platinum-resistant ovarian cancer, showing a 62% response rate in phase I trials.
InMode Ltd. updates shareholders on Special Committee's work
InMode Ltd. provides an update on its Special Committee's ongoing work to shareholders, emphasizing independence and commitment to best interests.
Selective Insurance Group Reports Strong Q3 Results
Selective Insurance Group Inc. showcases robust Q3 performance, impacting the fire, marine, and casualty insurance industry amid competitive pressures.
Orchid Island Capital reports Q3 results with asset growth
Orchid Island Capital, Inc. reveals Q3 financial results, highlighting growth in mortgage-backed securities, impacting the real estate investment trust sector.
Jumia Technologies AG Expands Management Board with New Appointments
Jumia Technologies AG has appointed three new members to its Management Board to strengthen leadership and drive growth in the retail-catalog sector.
GSK Reports 76% Response Rate for Jemperli in Cancer Trial
GSK plc announces a 76% complete response rate for Jemperli in a rectal cancer trial, marking a potential shift in treatment approaches.
Turkcell announces major share buy-back program
Turkcell Iletisim Hizmetleri A.S. initiates a buy-back of over 3 million shares to strengthen shareholder value and market position.
Coca-Cola FEMSA Reports Strong Q3 Results with Growth
Coca-Cola FEMSA announces impressive Q3 results, showcasing growth in revenue and operating income, reflecting resilience in the soft drinks industry.
CCH Holdings to Change Name to Foodverse Holding Limited
CCH Holdings Ltd announces plans to change its name to Foodverse Holding Limited, with an extraordinary general meeting scheduled for November 3, 2026.
Dr. Reddy's Laboratories Reports Q2 FY 2027 Financial Results
Dr. Reddy's Laboratories announces its financial results for Q2 FY 2027, revealing slight revenue decline but improved EBITDA margins.
Robot Consulting Faces Nasdaq Delisting Amid Trading Concerns
Robot Consulting Co., Ltd. receives a Nasdaq delisting determination and plans to appeal, raising concerns in the computer programming sector.
Dr. Reddy's Laboratories appoints Akhil Ravi as Head API
Dr. Reddy's Laboratories announces the appointment of Akhil Ravi as Head API and Services, effective November 13, 2026, enhancing its leadership team.
NatWest Group Announces Share Buyback from UBS AG
NatWest Group plc has initiated a significant share buyback, purchasing over 5 million shares from UBS AG, signaling a commitment to shareholder value.
BioNTech Reports Positive Phase 2 Data for Lung Cancer Drug
BioNTech SE reveals encouraging Phase 2 trial results for pumitamig, a lung cancer treatment, in collaboration with Bristol Myers Squibb.
CME Group reports Q3 2026 results with steady performance
CME Group Inc. reports its Q3 2026 financial results, showing steady performance in the competitive security and commodity brokerage sector.
Fury Gold Mines Reports High-Grade Gold Intersections
Fury Gold Mines Ltd announces significant assay results from its Eau Claire Gold Project, indicating high-grade mineralization and potential resource upgrades.
Dr. Reddy's Laboratories files significant SEC report
Dr. Reddy's Laboratories Ltd has filed a new SEC report detailing important updates that may affect its operations and the pharmaceutical industry.
BioNTech, DualityBio report Phase 3 trial results for breast cancer
BioNTech SE and DualityBiologics announce topline results from the DYNASTY-Breast02 Phase 3 trial, showing modest benefits for breast cancer treatment.